Account Info
Log Out
English
Back
Log in to access Online Inquiry
Back to the Top

Today's Pre-Market Stock Movers: BBY, BIDU, LCID, FSLR and More

avatar
Moomoo Breakfast US wrote a column · Aug 30, 2022 07:34
Gapping up
In reaction to earnings/guidance:
Other news:
$FREYR Battery(FREY.US)$ +11.4% (announces the execution of 38 GWh Li-Ion Battery binding cell sales agreement; enters into module & pack JV for energy storage solutions with Nidec)
$Avid Technology(AVID.US)$ +9.6% (to join S&P SmallCap 600)
$RVL Pharmaceuticals(RVLP.US)$ +2.3% (Revision Skincare announces strategic partnership withRVLP)
$North Mountain Merger Corp(NMMC.US)$ +2% (terminates previously announced merger with Corcentric)
$Dole plc(DOLE.US)$ +2% (Jan Barta disclosed 5.2% active stake last night)
$First Solar(FSLR.US)$ +1.8% (to invest up to $1.2 bln scaling production of American-made responsible solar by 4.4 GW)
$Netflix(NFLX.US)$ +1.4% (Netflix is denying a Bloomberg report that it’s mulling a $7 to $9 monthly charge for its upcoming ad-supported streaming service. )
$International Game Technology(IGT.US)$ +1.4% (IGT and DDI settle lawsuit)
$Haemonetics(HAE.US)$ +1.3% (announces deal with Epic to offer its SafeTrace Tx blood bank info to Epic's network of hospitals)
Analyst comments:
$American Outdoor Brands(AOUT.US)$ +5.5% (upgraded to Buy from Neutral at B. Riley Securities)
$Gap Inc(GPS.US)$ +3% (upgraded to Equal Weight from Underweight at Barclays)
$PDD Holdings(PDD.US)$ +3% (upgraded to Buy from Hold at HSBC Securities)
Gapping down
In reaction to earnings/guidance:
Other news:
$Sangamo Therapeutics(SGMO.US)$ -3.8% (Updated Preliminary Phase 1/2 Data in Fabry Disease Clinical Study Showing Continued Tolerability and Sustained Elevated a-gal A Enzyme Activity in Five Longest Treated Patients)
$Axos Financial(AX.US)$ -2% (files to delay 10-K due to required testing and validation of Axos Advisor Services activity having taken longer than anticipated)
$Lucid Group(LCID.US)$ -1.4% (files for $8 bln mixed securities shelf offering; also stock offering related to warrants)
Analyst comments:
$Molecular(MOLN.US)$ -5.8% (downgraded to Sector Perform from Outperform at RBC Capital Mkts)
Disclaimer: Moomoo Technologies Inc. is providing this content for information and educational use only. Read more
1
1
12
+0
4
Translate
Report
242K Views
Comment
Sign in to post a comment
avatar
Moomoo News Official Account
Explore and integrate top feeds before the bell
57KFollowers
13Following
56KVisitors
Follow